Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT05099770 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

685

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Chronic Kidney Diseases

Interventions

BIOLOGICAL: Renal Autologous Cell Therapy (REACT/ rilparencel)
PROCEDURE: Sham Comparator

Sponsor

Prokidney